Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid ReceptorsYazan J Meqbil, Richard M van RijnFrontiers in Pharmacology|November 29, 2023
ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitmentAlexander R French, Yazan J Meqbil, Richard M van RijnPharmaceutical Research|June 11, 2021
Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid OverdoseFarrokh Sharifi, Yazan J Meqbil, Andrew Otte, et al.The Journal of Pharmacology and Experimental Therapeutics|April 15, 2024
Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel <i>δ</i> Opioid Receptor-Selective Agonist ChemotypeYazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, et al.Molecules (Basel, Switzerland)|December 10, 2021
Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator CapabilitiesYazan J Meqbil, Hongyu Su, Robert J Cassell, et al.RSC Medicinal Chemistry|November 26, 2021
Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligandsKrishna K Sharma, Robert J Cassell, Yazan J Meqbil, et al.Journal of Medicinal Chemistry|February 24, 2023
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid ReceptorMadeline R Hennessy, Anna M Gutridge, Alexander R French, et al.Pageof 1